Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

On estimating efficacy from clinical trials.

A Sommer1, S L Zeger

  • 1Department of Ophthalmology, Johns Hopkins University, Baltimore, MD 21205.

Statistics in Medicine
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case of cutis verticis gyrata, induced by misuse of anabolic substances?

Clinical and experimental dermatology·2005
Same author

Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society·2005
Same author

Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.

The Journal of steroid biochemistry and molecular biology·2005
Same author

[Extensive, painful erosion of the vulva. Extramammary Paget disease].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2005
Same author

Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours.

European journal of cancer (Oxford, England : 1990)·2004
Same author

In vivo models for endocrine-dependent breast carcinomas: special considerations of clinical relevance.

European journal of cancer (Oxford, England : 1990)·2004
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

This study introduces a new method to estimate biologic efficacy in randomized trials, addressing limitations of traditional intent-to-treat analyses. The approach helps accurately measure treatment effects by comparing compliant groups while avoiding selection bias.

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Epidemiology

Background:

  • Biologic efficacy estimation in randomized trials is challenged by differential compliance between treatment and control groups.
  • Intent-to-treat (ITT) analysis, while standard, estimates programmatic effectiveness, not true biologic efficacy.
  • Comparing compliant subgroups directly can introduce selection bias due to differing compliance challenges.

Purpose of the Study:

  • To introduce and derive the statistical properties of a novel estimator for biologic efficacy.
  • To provide an alternative to ITT analysis that avoids selection bias in compliant subgroup comparisons.
  • To apply this new methodology to a randomized community trial on vitamin A supplementation and child mortality.

Main Methods:

  • Development of a new statistical estimator for biologic efficacy in randomized trials with dichotomous outcomes.

Related Experiment Videos

  • The method involves comparing compliers in the treatment group to an inferred, bias-eliminated control subgroup.
  • Application of the estimator to analyze the impact of vitamin A supplementation on children's mortality.

    • Main Results:

    • The proposed estimator provides a statistically sound method for assessing biologic efficacy.
    • It effectively mitigates selection bias that can arise from comparing compliant subgroups.
    • The methodology is demonstrated through its application in a real-world trial.

    Conclusions:

    • The novel estimator offers a more accurate assessment of biologic efficacy compared to traditional methods.
    • This approach enhances the validity of findings from randomized controlled trials.
    • Accurate biologic efficacy estimation is crucial for understanding true treatment effects, as shown in the vitamin A supplementation example.